WillItSurvive

GE HealthCare Technologies

Maker of medical imaging scanners, ultrasound, and diagnostics hardware plus software for hospitals worldwide.

Hard to displace
Assessed 20 July 2026 · Evidence as of 20 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 20 July 2026 · Checkable from July 29, 2026 · Every call on the record Checkpoint: Q2 2026 earnings report, first full quarter after guidance cut and Catholic Health deal
The call

A top-3 imaging maker with a huge backlog and long hospital contracts now facing tariff costs, securities lawsuits, and a race to fold AI into hardware faster than software rivals can route around it.

GE HealthCare makes hospital scanners, imaging software, and related services. It is hard to replace because hospitals sign long contracts with them, the U.S. government heavily regulates medical devices through the FDA, and GE owns both the physical machines and the software that analyzes scans, which small AI startups cannot do. The biggest question is whether hospital computer systems from companies like Epic or Oracle start bundling their own imaging software so fast that hospitals stop renewing their contracts with GE.

Why
01
AI pressure: Epic Systems, Oracle Health, and standalone AI radiology vendors like Subtle Medical. AI mostly gets bolted onto GE HealthCare's scanners via FDA clearances, but EHR platforms could route image analysis around its software layer someday. Could AI do the core job? Unlikely.
02
Bigger players: Siemens Healthineers and Philips. Both rivals compete for the same hospital contracts and AI-integrated platform deals, but neither is visibly pulling installed-base renewals away yet. Could a giant copy it? No, they are blocked.
03
What protects it. FDA-regulated hardware manufacturing, decades-long hospital service contracts, and proprietary clinical data that pure software vendors cannot replicate.
What would change this call
Q2 2026 earnings (July 29) margin trend versus the $250M tariff/inflation headwind. shows whether cost pressure is being absorbed or eroding profitability.
Whether Epic or Oracle Health announce direct AI-imaging integrations bypassing GEHC's stack. would show software rivals routing around GEHC's hardware-tied workflow.
Progress and backlog conversion from the Intelerad integration and Catholic Health alliance rollout. shows whether GEHC's software and services expansion is executing as planned.
Key numbers
  • FY2025 revenue $20.6B, net income $2.08B (FY2025)
  • Backlog $21.8B, book-to-bill 1.07x (Q1 2026)
  • $250M tariff and inflation headwind cut EPS guidance (Q1 2026)
Named risks
  • $250M tariff and inflation headwind pressuring FY2026 margins, mitigation weighted to H2 2026. Severity: high
  • Active securities-fraud investigations following the April 29, 2026 guidance cut and stock drop. Severity: medium
  • China revenue exposure (~13% as of 2023) amid intensifying local competition. Severity: medium
  • Execution risk integrating the $2.3B Intelerad acquisition closed March 18, 2026. Severity: medium
  • Third-party AI and cloud platforms commoditizing imaging software layers faster than GE can lock them into devices. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Siemens Healthineerscontesting~$26B revenue peer in imaging oligopoly, no visible share shift as of 2026
Philipscontesting~$19.7B revenue peer competing across CT, MR and ultrasound as of 2026
Subtle Medical and Cortechs/Microsoft (AI vendors)gaining onThird-party AI vendors circling imaging software layers noted as of 2026-06
Epic and Oracle Healthgaining onEHR/cloud platforms embedding AI into hospital imaging workflows, risk of bypassing GE stack, 2026
Questions people ask
Is GE HealthCare profitable in 2026?
Yes. GE HealthCare posted FY2025 net income of $2.08B on $20.6B revenue, and Q1 2026 revenue reached $5.13B, up 7.4% YoY. However, it cut FY2026 adjusted EPS guidance to $4.80-$5.00 on April 29, 2026, citing $250M in tariff and inflation costs.
Who is GE HealthCare's biggest competitor?
Siemens Healthineers (~$26B revenue) and Philips (~$19.7B revenue) are GE HealthCare's closest global peers in the medical imaging oligopoly as of 2026, alongside FUJIFILM and Canon Medical rounding out the top five imaging players.
Could AI replace GE HealthCare?
No. GE HealthCare embeds AI into its own FDA-regulated hardware and software, holding 100 listed FDA AI device authorizations as of July 2025 by the company's own count, four years running the most of any medical device maker. Pure software AI vendors cannot manufacture scanners or radiopharmaceuticals.
Is GE HealthCare a safe company to join in 2026?
Signals point to stability: LinkedIn-derived data shows 60,191 employees as of July 14, 2026, up from 59,146 in January 2026, and the company reported a record $21.8B order backlog in Q1 2026, even as an active securities-fraud investigation followed an April 2026 guidance cut.
Did GE HealthCare have layoffs in 2026?
No layoffs are reported; headcount trended upward. LinkedIn-tracked data shows 60,191 employees as of July 14, 2026, versus 59,146 in January 2026, and Macrotrends shows steady growth from 51,000 (2023) to 54,000 (2025).
Who owns GE HealthCare?
GE HealthCare Technologies (Nasdaq: GEHC) has been an independent public company since its January 2023 spinoff from General Electric. It is a sister company, not a subsidiary, of GE Aerospace and GE Vernova, both also products of GE's 2024 conglomerate breakup.
Timeline
  • 2026-07-17Announced 10-year, ~$500M Catholic Health Care Alliance covering 40+ sites and 1,300+ devices
  • 2026-07-14Stock fell 5.9% intraday to a low of $61.43
  • 2026-07-08Confirmed Q2 2026 earnings date of July 29, 2026; securities-fraud probe continues
  • 2026-06-04FDA 510(k) clearance for MIM Contour ProtegeAI+ 2.0 auto-contouring software with PCCP
  • 2026-04-29Q1 2026 report and EPS guidance cut to $4.80-$5.00 triggered 13% single-day stock drop
  • 2026-03-18Completed $2.3B acquisition of cloud imaging software firm Intelerad
  • 2025-11-20Announced agreement to acquire Intelerad for $2.3B cash
  • 2025-07-23Reported 100 FDA AI device authorizations, leading the industry for the 4th straight year
  • 2023-01Spun off from General Electric as independent Nasdaq-listed company
Head to head
Revision history
20 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources